Maxi Novel Company
Maxi Novel specializes in the fields of oral combination of tumor immunity, targeted drugs, and chemotherapy drugs.
Headquarters:
Shanghai,Shanghai,China,Asia
Founded Date:
2016-01-01
Industry:
Advanced BioTech R&D
Employee Number:
101-250
Sub-Industry:
PharmTech
Investors:
Longpan Investment, Dyee Capital, Youchoose Capital, Baifu Health
Ipo Status:
private
City:
Shanghai
Region:
Shanghai
Country:
China